Arthur Levin
Company: Avidity Biosciences
Job title: Chief Scientific Officer
Seminars:
Live Panel Q&A – Ask the Speakers your Burning Questions! 10:45 am
day: Day Two
Treating Diseases with Antibody Oligonucleotide Conjugates: Combining the Selectivity of Antibodies with the Specificity of Oligonucleotide Drugs 10:20 am
Antibody oligonucleotide conjugates utilize the selectivity of antibody delivery and the specificity of oligonucleotide therapeutics to treat diseases AOC1001 is designed to treat myotonic dystrophy type 1 Other AOCs are in development to address muscle disease and other disordersRead more
day: Day Two